Postpartum thyroiditis primary prevention: Difference between revisions
Jump to navigation
Jump to search
Usama Talib (talk | contribs) No edit summary |
Usama Talib (talk | contribs) |
||
| Line 8: | Line 8: | ||
==Primary Prevention== | ==Primary Prevention== | ||
*There are no established measures for the primary prevention of [[Postpartum thyroiditis]]. <ref name="pmid15157842">{{cite journal| author=Stagnaro-Green A| title=Postpartum thyroiditis. | journal=Best Pract Res Clin Endocrinol Metab | year= 2004 | volume= 18 | issue= 2 | pages= 303-16 | pmid=15157842 | doi=10.1016/j.beem.2004.03.008 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15157842 }} </ref> <ref name="pmid10874538">{{cite journal| author=Stagnaro-Green A| title=Recognizing, understanding, and treating postpartum thyroiditis. | journal=Endocrinol Metab Clin North Am | year= 2000 | volume= 29 | issue= 2 | pages= 417-30, ix | pmid=10874538 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10874538 }} </ref> | *There are no established measures for the primary prevention of [[Postpartum thyroiditis]]. <ref name="pmid15157842">{{cite journal| author=Stagnaro-Green A| title=Postpartum thyroiditis. | journal=Best Pract Res Clin Endocrinol Metab | year= 2004 | volume= 18 | issue= 2 | pages= 303-16 | pmid=15157842 | doi=10.1016/j.beem.2004.03.008 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15157842 }} </ref> <ref name="pmid10874538">{{cite journal| author=Stagnaro-Green A| title=Recognizing, understanding, and treating postpartum thyroiditis. | journal=Endocrinol Metab Clin North Am | year= 2000 | volume= 29 | issue= 2 | pages= 417-30, ix | pmid=10874538 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10874538 }} </ref> | ||
*However following are the common risk factors which increase chances of PPT | *However following are the common risk factors which increase chances of PPT: | ||
** Subsequent pregnancies | ** Subsequent pregnancies | ||
** [[smoking]] | ** [[smoking]] | ||
| Line 18: | Line 18: | ||
*** [[Interferon alpha]] | *** [[Interferon alpha]] | ||
*** [[Interleukin 2]] | *** [[Interleukin 2]] | ||
*** Highly active anti-retroviral therapy | *** Highly active anti-retroviral therapy | ||
==References== | ==References== | ||
Latest revision as of 17:43, 15 November 2017
|
Postpartum thyroiditis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Postpartum thyroiditis primary prevention On the Web |
|
American Roentgen Ray Society Images of Postpartum thyroiditis primary prevention |
|
Risk calculators and risk factors for Postpartum thyroiditis primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sunny Kumar MD [2]
Overview
There are no established measures for the primary prevention of postpartum thyroiditis. However, the common risk factors which increase chances of PPT are subsequent pregnancies, smoking, intake of iodine, radiation, and medications such as lithium, amiodarone, interferon alpha, interleukin 2, and the highly active antiretroviral therapy.
Primary Prevention
- There are no established measures for the primary prevention of Postpartum thyroiditis. [1] [2]
- However following are the common risk factors which increase chances of PPT:
- Subsequent pregnancies
- smoking
- Intake of iodine
- Radiation
- Medications:
- Lithium
- Amiodarone
- Interferon alpha
- Interleukin 2
- Highly active anti-retroviral therapy
References
- ↑ Stagnaro-Green A (2004). "Postpartum thyroiditis". Best Pract Res Clin Endocrinol Metab. 18 (2): 303–16. doi:10.1016/j.beem.2004.03.008. PMID 15157842.
- ↑ Stagnaro-Green A (2000). "Recognizing, understanding, and treating postpartum thyroiditis". Endocrinol Metab Clin North Am. 29 (2): 417–30, ix. PMID 10874538.